Search results for “Low Grade Malignant Neoplasm” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 1,319 patents, we discovered top 430 key players by total patent application. Taiho Pharmaceutical Co., Ltd., Shanghai Biowindow Gene Development Co. Ltd., Genentech, Inc. are dominant in this area. They take 9.78% of the total patent filing.
Tokyo-to, Japan
Patent: 53
Shanghai Shi, China
Patent: 50
California, United States
Patent: 26
New Jersey, United States
Patent: 21
Osaka-fu, Japan
Patent: 21
Hessen, Germany
Patent: 21
Jiangsu Sheng, China
Patent: 21
Basel-Stadt, Switzerland
Patent: 20
Gyeonggi-do, South Korea
Patent: 20
Shanghai Shi, China
Patent: 20
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 39 patents, we discovered top 17 start-ups by total patent application. Dayton Therapeutics AG, Institut National de la Santé et de la Recherche Médicale, KanonCure, Inc. are active in this area.
STARTUP
Dayton Therapeutics AG
Zug, Switzerland
Patent: 7
STARTUP
Tottori-ken, Japan
Patent: 4
STARTUP
Massachusetts, United States
Patent: 3
STARTUP
Beijing Shi, China
Patent: 3
STARTUP
United Kingdom
Patent: 2
STARTUP
United Kingdom
Patent: 2
STARTUP
United States
Patent: 2
STARTUP
Sichuan Sheng, China
Patent: 2
STARTUP
Beijing Shi, China
Patent: 1
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 968 patents applied in the last 5 years. We discover 390 most active companies in this area. The fast-growing Taiho Pharmaceutical Co., Ltd., Ono Pharmaceutical Co., Ltd., National Cancer Center Korea take 7.85% of patent filing during this period.
Tokyo-to, Japan
Patent: 38
Osaka-fu, Japan
Patent: 19
Gyeonggi-do, South Korea
Patent: 19
Minnesota, United States
Patent: 12
Massachusetts, United States
Patent: 11
New Jersey, United States
Patent: 10
California, United States
Patent: 10
Osaka-fu, Japan
Patent: 9
Osaka-fu, Japan
Patent: 9
Wisconsin, United States
Patent: 9
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 968 patents in last 5 years, we discover 302 new entrants. MEI Pharma, Inc., Sumitomo Pharmaceuticals Co., Ltd., L-Base Co., Ltd. are the most active new entrants in this area.
California, United States
Patent: 10
Osaka-fu, Japan
Patent: 9
South Korea
Patent: 7
STARTUP
Dayton Therapeutics AG
Zug, Switzerland
Patent: 7
Shanghai Shi, China
Patent: 7
Shanghai Shi, China
Patent: 7
Guangdong Sheng, China
Patent: 7
Jilin Sheng, China
Patent: 7
Tokyo-to, Japan
Patent: 7
Shanghai Shi, China
Patent: 7
Research Institutions
Order by:
Innovation Intensity
With the analysis among 469 patents, we discovered top 126 universities and scientific research institutions by total patent application. Fudan University, Jilin University, Shenzhen University are dominant in this area. They take 11.09% of the total patent filing.
Shanghai Shi, China
Patent: 12
Jilin Sheng, China
Patent: 7
Guangdong Sheng, China
Patent: 7
Louisiana, United States
Patent: 6
Tottori-ken, Japan
Patent: 6
Kanagawa-ken, Japan
Patent: 6
Shanghai Shi, China
Patent: 6
Texas, United States
Patent: 5
Jiangsu Sheng, China
Patent: 5
Jiangsu Sheng, China
Patent: 5
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: